Urgent termination of pregnancy in pre-eclampsia and panel of antiphospholipid antibodies

American Journal of Reproductive Immunology

Volumn 62, Issue 6, 2009, Pages 412-417

  Hradecky, Libor ^a   Subrt, Ivan ^a   Ulcova Gallova, Zdenka ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antiphospholipid antibodies; Pre eclampsia; Sectio caesarea

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; ETHANOLAMINE; GLYCEROL; IMMUNOGLOBULIN A; INOSITOL; LIPOCORTIN 5; PHOSPHATIDIC ACID; PHOSPHOLIPID ANTIBODY; SERINE;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PREECLAMPSIA; PREGNANCY TERMINATION; PRIORITY JOURNAL;

ABORTION, THERAPEUTIC; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PHOSPHOSERINE; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; THROMBOSIS;

EID: 70450197742     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00759.x     Document Type: Article

References (12)

1. Packner SC. Biochemical markers and physiological parameters as indices for identifying patients at risk of developing preeclampsia. J Hypertens 2004, 22:1-2.
2. Beer AE, Need JA. Immunological aspects of preeclampsia/eclampsia. Birth Defects Orig Artic Ser 1985, 21:131-154.
3. Talosi G, Endreffy E, Turi S, Nemeth I. Molecular and genetic aspects of preeclampsia: state of the art. Mol Genet Metab 2000, 71:565-572.
4. Clark EA, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?. Curr Rheumatol Rep 2007, 9:219-225.
5. Davison JM, Homuth V, Jeyabalan A, Conrad KP, Karumanchi SA, Quaggin S, Dechend R, Luft FC. New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol 2004, 15:2440-2448.
6. Ulcova-Gallova Z, Bouse V, Krizanovska K, Balvin M, Rokyta Z, Netrvalova L. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions. Int J Fertil 2001, 46:304-309.
7. Gleicher A, El-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastige. Am J Obstet Gynecol 1989, 160:1376-1381.
8. Oshiro BT, Silver MR, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1994, 84:294-297.
9. Carp HJ, Meroni PL, Shoenfeld Y. Autoantibodies as predictors of pregnancy complications. Rheumatology (Oxford) 2008, 47(Suppl. 3):1116-1118.
10. Chamley LW, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to beta 2-glycoprotein I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998, 352:1037-1308.
11. Gris JC, Quere I, Montpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, Hoffet M, Berlan J, Daurès JP, Marès P. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and non thrombotic antecedent - The Nimes Obstetricians and Haematologists study 5 (NOHA 5). Thromb Haemost 1999, 81:891-899.
12. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008, 112(2 Pt 1):359-372.